Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for DexCom, Inc. (DXCM : NSDQ)
 
 • Company Description   
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.

Number of Employees: 7,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $334.74 Daily Weekly Monthly
20 Day Moving Average: 843,603 shares
Shares Outstanding: 98.13 (millions)
Market Capitalization: $32,846.68 (millions)
Beta: 1.05
52 Week High: $659.45
52 Week Low: $302.61
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -31.98% -25.75%
12 Week -12.20% -5.11%
Year To Date -37.66% -26.16%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
6340 SEQUENCE DRIVE
-
SAN DIEGO,CA 92121
USA		 ph: 858-200-0200
fax: 858-200-0201		 investorrelations@dexcom.com http://www.dexcom.com
 
 • General Corporate Information   
Officers
Kevin R. Sayer - Chief Executive Officer. Chairman and President
Jereme M. Sylvain - Executive Vice President and Chief Financial Offic
Mark G. Foletta - Lead Independent Director
Steven R. Altman - Director
Nicholas Augustinos - Director

Peer Information
DexCom, Inc. (ABMD)
DexCom, Inc. (DMDS)
DexCom, Inc. (CPWY.)
DexCom, Inc. (EQUR)
DexCom, Inc. (ECIA)
DexCom, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 252131107
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 98.13
Most Recent Split Date: (:1)
Beta: 1.05
Market Capitalization: $32,846.68 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.71 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $3.28 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 10.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 17.39% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 102.18
Trailing 12 Months: 126.32
PEG Ratio: 5.88
Price Ratios
Price/Book: 15.00
Price/Cash Flow: 88.00
Price / Sales: 12.77
EPS Growth
vs. Year Ago Period: -3.03%
vs. Previous Quarter: -52.94%
Sales Growth
vs. Year Ago Period: 24.51%
vs. Previous Quarter: -9.94%
ROE
03/31/22 - 12.42
12/31/21 - 12.87
09/30/21 - 14.65
ROA
03/31/22 - 5.55
12/31/21 - 5.76
09/30/21 - 6.42
Current Ratio
03/31/22 - 5.27
12/31/21 - 5.11
09/30/21 - 4.98
Quick Ratio
03/31/22 - 4.79
12/31/21 - 4.62
09/30/21 - 4.50
Operating Margin
03/31/22 - 10.35
12/31/21 - 10.89
09/30/21 - 12.42
Net Margin
03/31/22 - 8.23
12/31/21 - 6.32
09/30/21 - 22.82
Pre-Tax Margin
03/31/22 - 6.56
12/31/21 - 7.10
09/30/21 - 12.50
Book Value
03/31/22 - 22.31
12/31/21 - 23.23
09/30/21 - 22.04
Inventory Turnover
03/31/22 - 2.45
12/31/21 - 2.33
09/30/21 - 2.38
Debt-to-Equity
03/31/22 - 0.90
12/31/21 - 0.76
09/30/21 - 0.80
Debt-to-Capital
03/31/22 - 47.31
12/31/21 - 43.06
09/30/21 - 44.37
 

Powered by Zacks Investment Research ©